Skip to content

Clinical trials

Phase 3 Coronary Artery Disease trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 3 Country / region: Japan Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20095
20101
20111
20121
20134
20141
20181
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Scientific Corporation5
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan3
AstraZeneca2
Bayer1
CSL Behring1
Janssen Research & Development, LLC1
Johns Hopkins University1
Novartis Pharmaceuticals1
Ono Pharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease16
Heart Diseases3
Stroke3
Acute Coronary Syndrome2
Atherosclerosis2
Coronary Disease2
Diabetes Mellitus2
Heart Failure2
Myocardial Infarction2
Peripheral Arterial Disease2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.